The major factors driving the growth of this market are the increasing adoption of single-use technologies and the growing demand for nanofiltration. Geographical expansion in countries such as Singapore, France, China, and India and the demand for polyamide track-etched membranes in ultrafiltration are likely to provide growth opportunities for players in the market.
The global Pharmaceutical Membrane Filtration Market is expected to grow from USD 5.8 billion in 2020 to USD 10.2
billion by 2025, at a CAGR of 12.0% from 2020 to 2025.
Ask
for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031
Market
Segmentation: -
Filters segment accounted for the largest share of
the pharmaceutical membrane filtration market, by product, in 2019
On the basis of product, the pharmaceutical
membrane filtration market is segmented into filters, systems, and accessories.
Filters formed the largest product segment in this market owing to the high and
growing use of different types of membrane filters for various filtration
applications in the biopharmaceutical manufacturing industry.
Final product processing segment accounted for the
largest share of the pharmaceutical membrane filtration market,
by application, in 2019
On the basis of application, the pharmaceutical membrane
filtration market is segmented into final product processing, raw material
filtration, cell separation, water purification, and air purification. Final
product processing was the largest application segment in the pharmaceutical
membrane filtration market in 2019. The increasing production of generics,
rapid growth in the biopharmaceutical industry, and the increasing adoption of
membrane filters in protein purification, sterile filtration, and viral
clearance processes are the major factors driving the growth of this
application segment.
Regional
Analysis: -
The global pharmaceutical membrane filtration
market is segmented into North America, Europe, the Asia Pacific, and the Rest
of the World. In 2019, North America was the largest market for pharmaceutical
membrane filtration, followed by Europe. The large share of North America can
be attributed to several factors, such as the presence of key biopharmaceutical
manufacturing facilities in the region and the significant spending on research
and development activities in the US.
Recent
Developments: -
- In 2018, Pall Corporation opened a center of excellence for
training on sterilization techniques, filtration, and cell culture
platforms.
- In 2018, GE Healthcare and the Swedish Government opened an
innovation center—Testa Center—in Sweden to support the commercialization
of advanced biopharmaceuticals.
- In 2016, Sartorius Stedim Biotech opened
its production and R&D facility in England.
Request
for Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=255408031
Key
Market Players: -
The
major companies operating in the pharmaceutical membrane filtration market
include Merck Millipore (Germany), Danaher (US) and Sartorius Stedim Biotech
(France).
No comments:
Post a Comment